Ms Dana Elise Shaw, MD | |
3436 Mary Elder Rd Ne, Olympia, WA 98506-5050 | |
(360) 528-2590 | |
Not Available |
Full Name | Ms Dana Elise Shaw |
---|---|
Gender | Female |
Speciality | Psychiatry |
Experience | 35 Years |
Location | 3436 Mary Elder Rd Ne, Olympia, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033279898 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | MD00031400 (Washington) | Primary |
Entity Name | Dana Shaw Md Ps |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598910812 PECOS PAC ID: 0941362164 Enrollment ID: O20081223000295 |
News Archive
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
Training emergency department staff in use of ultrasound to guide difficult peripheral intravenous catheter placement appears to reduce the unnecessary use of central venous lines, a study suggests.
Swimming in a pool of syrup would be difficult for most people, but for bacteria like E. coli, it's easier than swimming in water. Scientists have known for decades that these cells move faster and farther in viscoelastic fluids, such as the saliva, mucus, and other bodily fluids they are likely to call home, but didn't understand why.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Dana Elise Shaw, MD 3436 Mary Elder Rd Ne, Olympia, WA 98506-5050 Ph: (360) 528-2590 | Ms Dana Elise Shaw, MD 3436 Mary Elder Rd Ne, Olympia, WA 98506-5050 Ph: (360) 528-2590 |
News Archive
Obesity rates in the U.S. are driving up costs for employers that provide health insurance to workers, but few companies have introduced programs intended to curb the trend, the New York Times reports.
Training emergency department staff in use of ultrasound to guide difficult peripheral intravenous catheter placement appears to reduce the unnecessary use of central venous lines, a study suggests.
Swimming in a pool of syrup would be difficult for most people, but for bacteria like E. coli, it's easier than swimming in water. Scientists have known for decades that these cells move faster and farther in viscoelastic fluids, such as the saliva, mucus, and other bodily fluids they are likely to call home, but didn't understand why.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
› Verified 3 days ago
Dr. Lori Woehler, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9101 Steilacoom Rd Se Unit 26, Olympia, WA 98513 Phone: 425-785-1553 | |
Dr. Carol S. Wood, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2101 4th Ave E, Olympia, WA 98506 Phone: 360-786-9499 Fax: 360-786-0758 | |
Dr. David Peter Monson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2633a Parkmont Ln Sw, Ste F, Olympia, WA 98502 Phone: 360-870-8744 Fax: 360-352-3289 | |
Xinyi Liu, DBH, RDN Psychologist Medicare: Medicare Enrolled Practice Location: 3435 Martin Way E Ste C, Olympia, WA 98506 Phone: 786-838-3890 | |
Dr. Terilee Wingate, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3430 Pacific Ave Se Ste A6, Pmb 308, Olympia, WA 98501 Phone: 360-789-7918 | |
Dr. John Richter Van Eenwyk, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1026 State Ave Ne, Olympia, WA 98506 Phone: 360-352-2974 |